Publications To Date


    Filter Publications

    PAGE 62 OF 69 | DISPLAYING 916 - 930 OF 1024 RESULTS

    Gnant M. et al., Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone., [Epub ahead of print]., Annals Oncol., Dec 16, 2013

    Puig I. et al., A personalized preclinical model to evaluate the metastatic potential of patient-derived colon cancer initiating cells., [Epub ahead of print]., Clin Cancer Res., Dec 15, 2013

    Tan S. et al., Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma., [Epub ahead of print]., Clin. Cancer Res., Dec 09, 2013

    Spence T. et al., A novel C19MC amplified cell line links Lin28/let-7 to mTOR signaling in embryonal tumor with multilayered rosettes., [Epub ahead of print]., Neuro-Oncology, Dec 04, 2013

    Smallridge R.C. et al., RNA sequencing identifies multiple fusion transcripts, differentially expressed genes, and reduced expression of immune function genes in BRAF (V600E) mutant vs BRAF wild-type papillary thyroid carcinoma., [Epub ahead of print]., Journal of Clinical Endocrinology & Metabolism, Dec 02, 2013

    Bandopadhayay P. et al., BET-bromodomain inhibition of MYC-amplified Medulloblastoma., [Epub ahead of print]., Clin. Cancer Res., Dec 02, 2013

    Fierro-Monti I et al., Dynamic impacts of the inhibition of the molecular chaperone Hsp90 on the T-cell proteome have implications for anti-cancer therapy., [Epub ahead of print]., PLoS ONE, Nov 27, 2013

    Norton N. et al., Gene expression, single nucleotide variant and fusion transcript discovery in archival material from breast tumors., [Epub ahead of print]., PLoS ONE, Nov 22, 2013

    Iida N. et al., Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment., [Epub ahead of print]., Science, Nov 22, 2013

    Pogue-Geile K.L. et al., Predicting degree of benefit from adjuvant Trastuzumab in NSABP trial B-31., [Epub ahead of print]., J Natl Cancer Inst., Nov 21, 2013

    Sun J.M. et al., Clinical characteristics associated with ALK rearrangements in never-smokers with pulmonary adenocarcinoma., [Epub ahead of print]., Lung Cancer, Nov 20, 2013

    Paulus A. et al., AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenström macroglobulinaemia., [Epub ahead of print]., British J. Haematol., Nov 17, 2013

    Kastenhuber E.R. et al., Quantitative assessment of intragenic receptor tyrosine kinase deletions in primary glioblastomas: their prevalence and molecular correlates., [Epub ahead of print]., Acta Neuropathol, Nov 13, 2013

    Tothill R.W. et al., Massively-parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary., [Epub ahead of print]., Journal of Pathology, Nov 12, 2013

    Bali K.K. et al., Genome-wide identification and functional analyses of microRNA signatures associated with cancer pain., 5(11):1740-1758., EMBO Molecular Medicine, Nov 07, 2013